medigraphic.com

2011, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (5)

Optimization of creatinine measurement for laboratory estimation of glomerular filtration rate

Da Silvera-Martínez R, Jiménez-Gutiérrez R

Language: Spanish
References: 33
Page: 481-486
PDF size: 39.02 Kb.


ABSTRACT

Objective: to analyze the optimization of serum creatinine in the report of the estimation of glomerular filtration rate (GFR) for laboratory in groups of patients on overweight, obesity, hypertension, and diabetes named SOHDi, and how much have learned about their disease, stress control, diet and exercise, which are problems with more risk associated to kidney disease.
Methods: The serum creatinine results in the Family Medicine Unit No. 34, IMSS, at Jalisco, was analyzed in a transversal study, from January to December of 2008. GFR was estimated with the Cockcroft-Gault formulary. Statistical analysis with multivariate logistic regression analyses was performed.
Results: the sample was 8331 patients’; 23.5 % with GFR ‹ 60 mL/minute/1.73 m2, and 9.1 % creatinine serum › 1.5 mg/dL. Associated factors were age ‹ 19 years, woman age 19 to 59 years, and SOHDi.
Conclusions: the study suggested that participating in groups SOHDi, and be women are protector factors for felt down on GFR. The people ‹ 19 years had lesser GFR.


REFERENCES

  1. Hamer R, El Nahas AM. The burden of chronic kidney disease. BMJ 2006;332(7541):563-564.

  2. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006;333(7577);1047.

  3. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110(1):32-35.

  4. Instituto Nacional de Salud Publica. [Sitio Web]. Encuesta Nacional en Salud y Nutrición 2006. México: Secretaría de Salud; 2006. Disponible en http://www.insp.mx/ images/stories/ENSANUT/Docs/Ensanut2006.pdf

  5. Ravid M, Lang R, Tachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes melltus: a 7-years follow-up study. Arch Intern Med 1996;156(3):286-289.

  6. Instituto Mexicano del Seguro Social. [Sitio web]. Preveimss. México: IMSS. Disponible en http://www.imss.gob. mx/Delegaciones/Chihuahua/PrevenIMSS.htm

  7. Instituto Mexicano del Seguro Social [sede Web]. México; IMSS. Disponible en http://www.imss.gob.mx/NR/ rdonelyres/1104CECE-B2B2-496E-9C2C-91B455D41360/ mejora.pdf

  8. Levin A. Identification of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant 2001;16(Suppl 7): 57-60.

  9. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007;30(Suppl 1): S4-S41.

  10. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007;30(Suppl 1):S4-S41.

  11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266.

  12. Levinsky NG. Specialist evaluation in chronic kidney disease: too little, too late. Ann Intern Med 2002;137(6):542-543.

  13. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parvig et al. American Diabetes Association. Nephrolgy in diabetes. Diabetes Care 2004;27(Suppl 1):S79-S83.

  14. Grag JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 2002;7(1):35-42.

  15. Klausen K, Borch-Jonsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110(1):32-35.

  16. Gall MA, Hougaard P, Borch-Jonsen K, Parving HH. Risk factors for development of incipient and overt diabetic nepgropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997;314(7083):783-788.

  17. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289(24):3273-3277.

  18. Tsalamandris C, Alln TJ, Cilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, et.al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 1994;43(5):649-655.

  19. Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care 2005;28(7):1813-1816.

  20. Murphy JE, Preuss HG, Henry JB. Evaluación de la función renal y del equilibrio hidroelectrolítico y acidobásico. En: Henrry JB. Diagnóstico y tratamiento clínico por el laboratorio. España: Salvat; 1988. p. 147-149.

  21. Cockcroft DW, Gault, MH. Predicting creatinine clearance from serum creatinine. Nephron 1976;16(1):31-41.

  22. National Kidney Foundation. [Sitio web]. Calculators for Health Care Professionals. Disponible en www.kidney. org/professionals/kdoqi/gfr_calculator.cfm

  23. Graystone J. Creatinine excretion during grown. En: Cheek DB editor. Human growth. Philadelphia, USA: Lea and Febiger; 1968. p. 182.

  24. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139(2):137-147.

  25. Mathew TH, Australian Creatinine Consensus Working Group. Chronic kidney disease and automatic reportin of estimated glomerular filtration rate: a position statement. Med J Aust 2005;183(3):138-141.

  26. Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003;163(3):356-360.

  27. Hemmelgarn BR, Zhang J, Mann BJ, James MT, Quinn RR, Ravani P, et al. Nephrology visits and health care resource use before and after reporting estimated gomerular filtrarion Rate. JAMA 2010;303(12):1151-1158.

  28. Murphee DD, Thelen SM. Chronic kidney disease in primary care. J Am Board Fam Med 2010;23(4):542-550.

  29. Leyva-Jiménez R, Álvarez-Aguilar C, López-Molina MG. Función renal en diabéticos tipo 2, determinada por fórmula de Cockcroft-Gault y depuración de creatinina. Rev Med IMSS 2004;42(1):5-10.

  30. Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care 2005;28(7)1813-1816.

  31. Helou R. Should we continue to use the Cockroft-Gault formula? Nephron Clin Pract 2010:116(3):c172-c186. Discussion c186. Epub 2010 Jul 2.

  32. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survery (NHANES III). J Am Soc Nephrol 2002;13:1338-1349

  33. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11- S61.




2020     |     www.medigraphic.com